| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo
|
Gillespie, J.
|
|
2008
|
26 |
Supplement 3 |
p. 4231-4236
6 p.
|
artikel
|
| 2 |
A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge
|
Pretorius, A.
|
|
2008
|
26 |
Supplement 3 |
p. 4363-4371
9 p.
|
artikel
|
| 3 |
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
|
Verstraeten, Thomas
|
|
2008
|
26 |
Supplement 3 |
p. 6630-6638
9 p.
|
artikel
|
| 4 |
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine
|
Awasthi, Sita
|
|
2008
|
26 |
Supplement 3 |
p. 1195-1203
9 p.
|
artikel
|
| 5 |
Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3)
|
Perelberg, Ayana
|
|
2008
|
26 |
Supplement 3 |
p. 3750-3756
7 p.
|
artikel
|
| 6 |
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
|
Schiller, John T.
|
|
2008
|
26 |
Supplement 3 |
p. K53-K61
nvt p.
|
artikel
|
| 7 |
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
|
Martin, Julie E.
|
|
2008
|
26 |
Supplement 3 |
p. 6338-6343
6 p.
|
artikel
|
| 8 |
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results
|
Dhiman, Neelam
|
|
2008
|
26 |
Supplement 3 |
p. 1731-1736
6 p.
|
artikel
|
| 9 |
Attenuated West Nile viruses bearing 3′SL and envelope gene substitution mutations
|
Yu, Li
|
|
2008
|
26 |
Supplement 3 |
p. 5981-5988
8 p.
|
artikel
|
| 10 |
Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination
|
McKinley, Enid T.
|
|
2008
|
26 |
Supplement 3 |
p. 1274-1284
11 p.
|
artikel
|
| 11 |
Bioneedles™ as vaccine carriers
|
Hirschberg, Hoang J.H.B.
|
|
2008
|
26 |
Supplement 3 |
p. 2389-2397
9 p.
|
artikel
|
| 12 |
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection
|
Ogunniyi, Abiodun D.
|
|
2008
|
26 |
Supplement 3 |
p. 4676-4685
10 p.
|
artikel
|
| 13 |
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
|
Guy, Bruno
|
|
2008
|
26 |
Supplement 3 |
p. 5712-5721
10 p.
|
artikel
|
| 14 |
Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice
|
Phumoonna, Tongted
|
|
2008
|
26 |
Supplement 3 |
p. 2457-2465
9 p.
|
artikel
|
| 15 |
Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge
|
Sánchez, Oliberto
|
|
2008
|
26 |
Supplement 3 |
p. 988-997
10 p.
|
artikel
|
| 16 |
Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis
|
Gates, A.E.
|
|
2008
|
26 |
Supplement 3 |
p. 2010-2019
10 p.
|
artikel
|
| 17 |
Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children
|
Givon-Lavi, Noga
|
|
2008
|
26 |
Supplement 3 |
p. 5798-5801
4 p.
|
artikel
|
| 18 |
Comparison of epidemiologic methods for active surveillance of vaccine safety
|
McClure, David L.
|
|
2008
|
26 |
Supplement 3 |
p. 3341-3345
5 p.
|
artikel
|
| 19 |
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs
|
Hoshino, Yo
|
|
2008
|
26 |
Supplement 3 |
p. 4034-4040
7 p.
|
artikel
|
| 20 |
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
|
Gatchalian, Salvacion
|
|
2008
|
26 |
Supplement 3 |
p. 2234-2241
8 p.
|
artikel
|
| 21 |
Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV
|
Yang, Songtao
|
|
2008
|
26 |
Supplement 3 |
p. 1482-1487
6 p.
|
artikel
|
| 22 |
Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum
|
Xie, Yong
|
|
2008
|
26 |
Supplement 3 |
p. 3452-3460
9 p.
|
artikel
|
| 23 |
Cost and cost-effectiveness of childhood vaccination against rotavirus in France
|
Melliez, H.
|
|
2008
|
26 |
Supplement 3 |
p. 706-715
10 p.
|
artikel
|
| 24 |
Cost-effectiveness of adult pertussis vaccination in Germany
|
Lee, Grace M.
|
|
2008
|
26 |
Supplement 3 |
p. 3673-3679
7 p.
|
artikel
|
| 25 |
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073
|
Fytili, P.
|
|
2008
|
26 |
Supplement 3 |
p. 3818-3826
9 p.
|
artikel
|
| 26 |
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants
|
Palma, Paolo
|
|
2008
|
26 |
Supplement 3 |
p. 5196-5201
6 p.
|
artikel
|
| 27 |
Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
|
Blaney Jr., Joseph E.
|
|
2008
|
26 |
Supplement 3 |
p. 817-828
12 p.
|
artikel
|
| 28 |
Detecting AIDS restriction genes: From candidate genes to genome-wide association discovery
|
Hutcheson, H.B.
|
|
2008
|
26 |
Supplement 3 |
p. 2951-2965
15 p.
|
artikel
|
| 29 |
Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium
|
Pohlscheidt, M.
|
|
2008
|
26 |
Supplement 3 |
p. 1552-1565
14 p.
|
artikel
|
| 30 |
Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults
|
Tang, Roderick S.
|
|
2008
|
26 |
Supplement 3 |
p. 6373-6382
10 p.
|
artikel
|
| 31 |
DNA vaccine protects ornamental koi (Cyprinus carpio koi) against North American spring viremia of carp virus
|
Emmenegger, E.J.
|
|
2008
|
26 |
Supplement 3 |
p. 6415-6421
7 p.
|
artikel
|
| 32 |
Double-stranded RNA- and CpG DNA-induced immune responses in Atlantic salmon: Comparison and synergies
|
Strandskog, Guro
|
|
2008
|
26 |
Supplement 3 |
p. 4704-4715
12 p.
|
artikel
|
| 33 |
Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia
|
Shefer, Abigail
|
|
2008
|
26 |
Supplement 3 |
p. K68-K75
nvt p.
|
artikel
|
| 34 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 35 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 36 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 3 |
p. CO2-
1 p.
|
artikel
|
| 37 |
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway
|
Vestrheim, Didrik F.
|
|
2008
|
26 |
Supplement 3 |
p. 3277-3281
5 p.
|
artikel
|
| 38 |
Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden
|
Spindler, Carl
|
|
2008
|
26 |
Supplement 3 |
p. 5541-5546
6 p.
|
artikel
|
| 39 |
Efficacies of inactivated vaccines against betanodavirus in grouper larvae (Epinephelus coioides) by bath immunization
|
Kai, Yu-Hsuan
|
|
2008
|
26 |
Supplement 3 |
p. 1450-1457
8 p.
|
artikel
|
| 40 |
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990–2006
|
Chang, Soju
|
|
2008
|
26 |
Supplement 3 |
p. 2428-2432
5 p.
|
artikel
|
| 41 |
Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice
|
Wei, Feng
|
|
2008
|
26 |
Supplement 3 |
p. 4145-4149
5 p.
|
artikel
|
| 42 |
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
|
Bosch, F. Xavier
|
|
2008
|
26 |
Supplement 3 |
p. K1-K16
nvt p.
|
artikel
|
| 43 |
Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys
|
Blaney Jr., Joseph E.
|
|
2008
|
26 |
Supplement 3 |
p. 4150-4159
10 p.
|
artikel
|
| 44 |
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
|
Kemp, Troy J.
|
|
2008
|
26 |
Supplement 3 |
p. 3608-3616
9 p.
|
artikel
|
| 45 |
Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals
|
Rizza, Paola
|
|
2008
|
26 |
Supplement 3 |
p. 1038-1049
12 p.
|
artikel
|
| 46 |
Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals
|
von Teichman, Beate F.
|
|
2008
|
26 |
Supplement 3 |
p. 5014-5021
8 p.
|
artikel
|
| 47 |
Evaluation of widely consumed botanicals as immunological adjuvants
|
Ragupathi, Govind
|
|
2008
|
26 |
Supplement 3 |
p. 4860-4865
6 p.
|
artikel
|
| 48 |
First generation leishmaniasis vaccines: A review of field efficacy trials
|
Noazin, Sassan
|
|
2008
|
26 |
Supplement 3 |
p. 6759-6767
9 p.
|
artikel
|
| 49 |
Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife
|
Geue, Lutz
|
|
2008
|
26 |
Supplement 3 |
p. 3227-3235
9 p.
|
artikel
|
| 50 |
“Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
|
Edelman, Robert
|
|
2008
|
26 |
Supplement 3 |
p. 4113-4119
7 p.
|
artikel
|
| 51 |
HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: Implications for therapy and vaccine development
|
Jacobs, Amy
|
|
2008
|
26 |
Supplement 3 |
p. 3026-3035
10 p.
|
artikel
|
| 52 |
Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis
|
Khan, Arif Azam
|
|
2008
|
26 |
Supplement 3 |
p. 316-332
17 p.
|
artikel
|
| 53 |
Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy
|
Valor, L.
|
|
2008
|
26 |
Supplement 3 |
p. 2738-2745
8 p.
|
artikel
|
| 54 |
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3
|
Gartner, Tatiana
|
|
2008
|
26 |
Supplement 3 |
p. 1458-1470
13 p.
|
artikel
|
| 55 |
Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial
|
Jiang, Wei-Ping
|
|
2008
|
26 |
Supplement 3 |
p. 2297-2301
5 p.
|
artikel
|
| 56 |
Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population
|
Leach, Amanda J.
|
|
2008
|
26 |
Supplement 3 |
p. 3885-3891
7 p.
|
artikel
|
| 57 |
Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants
|
Olivier, C.
|
|
2008
|
26 |
Supplement 3 |
p. 3142-3152
11 p.
|
artikel
|
| 58 |
Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis
|
West, Nicholas P.
|
|
2008
|
26 |
Supplement 3 |
p. 3853-3859
7 p.
|
artikel
|
| 59 |
Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams
|
Muñoz, Pilar-María
|
|
2008
|
26 |
Supplement 3 |
p. 2562-2569
8 p.
|
artikel
|
| 60 |
Importance of the major Fli C antigenic site of Salmonella enteritidis as a subunit vaccine antigen
|
Toyota-Hanatani, Yukiko
|
|
2008
|
26 |
Supplement 3 |
p. 4135-4137
3 p.
|
artikel
|
| 61 |
Inactivated rotavirus vaccines: A priority for accelerated vaccine development
|
Jiang, Baoming
|
|
2008
|
26 |
Supplement 3 |
p. 6754-6758
5 p.
|
artikel
|
| 62 |
Influenza vaccine effectiveness and confounding factors among young children
|
Fujieda, Megumi
|
|
2008
|
26 |
Supplement 3 |
p. 6481-6485
5 p.
|
artikel
|
| 63 |
Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel
|
Swartz, T.A.
|
|
2008
|
26 |
Supplement 3 |
p. 1083-1090
8 p.
|
artikel
|
| 64 |
Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue
|
Sabirov, Albert
|
|
2008
|
26 |
Supplement 3 |
p. 1566-1576
11 p.
|
artikel
|
| 65 |
Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
|
Andrus, Jon Kim
|
|
2008
|
26 |
Supplement 3 |
p. K87-K92
nvt p.
|
artikel
|
| 66 |
In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets
|
Linghua, Zhang
|
|
2008
|
26 |
Supplement 3 |
p. 224-233
10 p.
|
artikel
|
| 67 |
Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine
|
Fei-fei, Ge
|
|
2008
|
26 |
Supplement 3 |
p. 5590-5594
5 p.
|
artikel
|
| 68 |
Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers
|
Littmann, Martina
|
|
2008
|
26 |
Supplement 3 |
p. 2344-2349
6 p.
|
artikel
|
| 69 |
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization
|
Gudmundsdotter, Lindvi
|
|
2008
|
26 |
Supplement 3 |
p. 5107-5110
4 p.
|
artikel
|
| 70 |
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses
|
Megati, Shakuntala
|
|
2008
|
26 |
Supplement 3 |
p. 5083-5094
12 p.
|
artikel
|
| 71 |
Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures
|
Jäkel, Anne
|
|
2008
|
26 |
Supplement 3 |
p. 6655-6663
9 p.
|
artikel
|
| 72 |
Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates
|
Fine, Donald L.
|
|
2008
|
26 |
Supplement 3 |
p. 3497-3506
10 p.
|
artikel
|
| 73 |
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
|
Taylor, Claribel P.
|
|
2008
|
26 |
Supplement 3 |
p. 3404-3409
6 p.
|
artikel
|
| 74 |
Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2
|
Zhang, Hong-Ying
|
|
2008
|
26 |
Supplement 3 |
p. 769-777
9 p.
|
artikel
|
| 75 |
Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies
|
Zhang, Shoufeng
|
|
2008
|
26 |
Supplement 3 |
p. 345-350
6 p.
|
artikel
|
| 76 |
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
|
Cuzick, Jack
|
|
2008
|
26 |
Supplement 3 |
p. K29-K41
nvt p.
|
artikel
|
| 77 |
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
|
Kester, Kent E.
|
|
2008
|
26 |
Supplement 3 |
p. 2191-2202
12 p.
|
artikel
|
| 78 |
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers
|
Sadorge, Christine
|
|
2008
|
26 |
Supplement 3 |
p. 978-987
10 p.
|
artikel
|
| 79 |
Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage
|
Erdem, Hakan
|
|
2008
|
26 |
Supplement 3 |
p. 1271-1273
3 p.
|
artikel
|
| 80 |
Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs
|
Manickam, R.
|
|
2008
|
26 |
Supplement 3 |
p. 6564-6568
5 p.
|
artikel
|
| 81 |
Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data
|
Bailleux, F.
|
|
2008
|
26 |
Supplement 3 |
p. 3903-3908
6 p.
|
artikel
|
| 82 |
Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein
|
Gorman, Shelley
|
|
2008
|
26 |
Supplement 3 |
p. 3860-3869
10 p.
|
artikel
|
| 83 |
Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle
|
Chang, Byoung Sun
|
|
2008
|
26 |
Supplement 3 |
p. 2081-2091
11 p.
|
artikel
|
| 84 |
Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions
|
Veits, Jutta
|
|
2008
|
26 |
Supplement 3 |
p. 1688-1696
9 p.
|
artikel
|
| 85 |
Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 Hookworm Vaccine in unexposed adults
|
Bethony, Jeffrey M.
|
|
2008
|
26 |
Supplement 3 |
p. 2408-2417
10 p.
|
artikel
|
| 86 |
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
|
Herrero, Rolando
|
|
2008
|
26 |
Supplement 3 |
p. 4795-4808
14 p.
|
artikel
|
| 87 |
Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands
|
David, Silke
|
|
2008
|
26 |
Supplement 3 |
p. 5883-5887
5 p.
|
artikel
|
| 88 |
Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults
|
Roukens, A.H.
|
|
2008
|
26 |
Supplement 3 |
p. 3438-3442
5 p.
|
artikel
|
| 89 |
Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2
|
Kixmöller, Marion
|
|
2008
|
26 |
Supplement 3 |
p. 3443-3451
9 p.
|
artikel
|
| 90 |
Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children
|
Esteghamati, Abdoulreza
|
|
2008
|
26 |
Supplement 3 |
p. 5058-5061
4 p.
|
artikel
|
| 91 |
Report of the third meeting on “Influenza vaccines that induce broad spectrum and long-lasting immune responses”, World Health Organization, Geneva, Switzerland, 3–4 December 2007
|
Girard, Marc P.
|
|
2008
|
26 |
Supplement 3 |
p. 2443-2450
8 p.
|
artikel
|
| 92 |
Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice
|
Hinkula, Jorma
|
|
2008
|
26 |
Supplement 3 |
p. 5101-5106
6 p.
|
artikel
|
| 93 |
Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age
|
Pietrzyk, Jacek J.
|
|
2008
|
26 |
Supplement 3 |
p. 5296-5303
8 p.
|
artikel
|
| 94 |
Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants
|
Li, Rong Cheng
|
|
2008
|
26 |
Supplement 3 |
p. 2260-2269
10 p.
|
artikel
|
| 95 |
Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses
|
Sigurdardottir, Sigurveig Th.
|
|
2008
|
26 |
Supplement 3 |
p. 4178-4186
9 p.
|
artikel
|
| 96 |
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China
|
Zhu, Feng Cai
|
|
2008
|
26 |
Supplement 3 |
p. 4579-4584
6 p.
|
artikel
|
| 97 |
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
|
Sacarlal, Jahit
|
|
2008
|
26 |
Supplement 3 |
p. 174-184
11 p.
|
artikel
|
| 98 |
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines
|
Prymula, Roman
|
|
2008
|
26 |
Supplement 3 |
p. 4563-4570
8 p.
|
artikel
|
| 99 |
Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine
|
Silva, Ana Carina
|
|
2008
|
26 |
Supplement 3 |
p. 3305-3311
7 p.
|
artikel
|
| 100 |
Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections
|
Zhan, Xiaoyan
|
|
2008
|
26 |
Supplement 3 |
p. 3480-3488
9 p.
|
artikel
|
| 101 |
Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel
|
Singer, Darrell E.
|
|
2008
|
26 |
Supplement 3 |
p. 869-873
5 p.
|
artikel
|
| 102 |
Sexual dimorphism of humoral immunity with human vaccines
|
Cook, Ian Francis
|
|
2008
|
26 |
Supplement 3 |
p. 3551-3555
5 p.
|
artikel
|
| 103 |
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
|
Block, Stan L.
|
|
2008
|
26 |
Supplement 3 |
p. 4940-4946
7 p.
|
artikel
|
| 104 |
Strategies for financial sustainability of immunization programs: A review of the strategies from 50 national immunization program financial sustainability plans
|
Kamara, Lidija
|
|
2008
|
26 |
Supplement 3 |
p. 6717-6726
10 p.
|
artikel
|
| 105 |
Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine
|
Lang, Krystle A.
|
|
2008
|
26 |
Supplement 3 |
p. 6225-6231
7 p.
|
artikel
|
| 106 |
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia
|
Borkowsky, William
|
|
2008
|
26 |
Supplement 3 |
p. 3086-3089
4 p.
|
artikel
|
| 107 |
TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area—Impact on current recommendations for immunization of high-risk groups
|
Plíšek, Stanislav
|
|
2008
|
26 |
Supplement 3 |
p. 301-304
4 p.
|
artikel
|
| 108 |
The antifertility effects of DNA vaccine-induced immune responses against uroguanylin
|
Sun, Jing
|
|
2008
|
26 |
Supplement 3 |
p. 3696-3704
9 p.
|
artikel
|
| 109 |
The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries
|
Cook, Joseph
|
|
2008
|
26 |
Supplement 3 |
p. 6305-6316
12 p.
|
artikel
|
| 110 |
The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex
|
Fachinger, Vicky
|
|
2008
|
26 |
Supplement 3 |
p. 1488-1499
12 p.
|
artikel
|
| 111 |
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
|
But, David Yiu-Kuen
|
|
2008
|
26 |
Supplement 3 |
p. 6587-6591
5 p.
|
artikel
|
| 112 |
Vaccination of cattle against tropical theileriosis in Uzbekistan using autochthonous live vaccine
|
Rasulov, Ilhan
|
|
2008
|
26 |
Supplement 3 |
p. G14-G16
nvt p.
|
artikel
|
| 113 |
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
|
Vandepapelière, Pierre
|
|
2008
|
26 |
Supplement 3 |
p. 1375-1386
12 p.
|
artikel
|
| 114 |
WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay
|
Knezevic, I.
|
|
2008
|
26 |
Supplement 3 |
p. 3960-3968
9 p.
|
artikel
|
| 115 |
Willingness of Chinese injection drug users to participate in HIV vaccine trials
|
Yin, Lu
|
|
2008
|
26 |
Supplement 3 |
p. 762-768
7 p.
|
artikel
|
Tijdschrift beschrijving